Vaccine side effects very rare, says DDC

Vaccine side effects very rare, says DDC

Few side effects have been reported among the 120 million Covid-19 vaccine doses administered, according to the Department of Disease Control (DDC).

Dr Chawetsan Namwat, director of the Emergency Health Hazard and Disease Control Division under the DDC, confirmed the number and distribution of reported adverse reactions as of Feb 13.

The 120 million doses so far comprise: 26.4 million Sinovac, 46.8 million AstraZeneca, 14.7 million Sinopharm, 27.6 million Pfizer and 4.3 million Moderna doses, Dr Chawetsan said.

He said that 79 people were found to have developed allergic reactions to their vaccines. These comprise 43 affected by Sinovac, 22 by AstraZeneca, three by Sinopharm and 11 by Pfizer.

Dr Chawetsan said 31 people have reportedly suffered from pericarditis after receiving jabs with 29 being attributed to Pfizer and one each to AstraZeneca and Sinopharm. Thrombosis with thrombocytopenia occurred in six people, five of whom were injected with AstraZeneca and one with the Pfizer vaccine.

The government has received 2,081 complaints of people dying as a result of side effects from Covid vaccines. But only four have been confirmed: two from thrombosis with thrombocytopenia, one due to severe shock, and another attributed to Stevens-Johnson syndrome.

Some 177 deaths reportedly stemmed from severe symptoms such as heart disease, intracerebral haemorrhage and thrombosis, while 938 deaths were attributed to an infected nervous system, pneumonitis, and other factors. However the underlying causes could not be confirmed.

Do you like the content of this article?
COMMENT (4)

Next stop: Isan

Typhoon Noru tears roofs from homes and causes power outages across central Vietnam as it is moving towards Ubon Ratchathani and Amnat Charoen.

28 Sep 2022

Thai spikers beat Croatia, to meet South Korea Thursday

Thailand's volleyball team cruised past Croatia on Wednesday in their third match at the FIVB Women's World Championship in Gdansk, Poland.

28 Sep 2022

Indonesia approves first home-grown Covid vaccine for emergency use

JAKARTA: Indonesia has approved its first domestically-produced Covid-19 vaccine for emergency use for people over 18, the chief of the country's food and drugs agency (BPOM) was quoted by news media as saying on Wednesday.

28 Sep 2022